exatecan mesylate

DRUG16 trials

Sponsors

Daiichi Sankyo, Daiichi Pharmaceuticals, European Organisation for Research and Treatment of Cancer - EORTC, Jonsson Comprehensive Cancer Center

Conditions

Brain and Central Nervous System TumorsBreast CancerCervical CancerEsophageal CancerExtrahepatic Bile Duct CancerFallopian Tube CancerGallbladder CancerGastric Cancer

Phase 1

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

CompletedNCT00004212

Daiichi SankyoBrain and Central Nervous System Tumors, Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific

Start: 1999-09-30End: 2004-04-30Updated: 2012-05-16

Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction

CompletedNCT00045318

Jonsson Comprehensive Cancer CenterUnspecified Adult Solid Tumor, Protocol Specific

Start: 2002-05-31End: 2007-10-31Updated: 2013-07-10

Chemotherapy in Treating Patients Who Have Hematologic Cancer

CompletedNCT00004047

Daiichi SankyoLeukemia, Myelodysplastic Syndromes

Start: 1999-06-30End: 2005-04-30Updated: 2012-05-16

Phase 2

DX-8951f in Treating Patients With Metastatic Stomach Cancer

CompletedNCT00017212

Daiichi SankyoEsophageal Cancer, Gastric Cancer

Start: 2001-04-30End: 2003-09-30Updated: 2012-05-16

DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix

CompletedNCT00004866

Daiichi SankyoCervical Cancer

Start: 2000-01-31End: 2003-09-30Updated: 2012-05-16

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

CompletedNCT00041236

European Organisation for Research and Treatment of Cancer - EORTCSarcoma

Start: 2002-05-31Updated: 2012-07-18

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

CompletedNCT00055952

Daiichi SankyoSarcoma

Start: 2003-01-31End: 2006-04-30Updated: 2012-05-16

Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma

CompletedNCT00055939

Daiichi SankyoSarcoma

Start: 2003-01-31End: 2006-04-30Updated: 2012-05-16

Chemotherapy in Treating Women With Metastatic Breast Cancer

CompletedNCT00004046

Daiichi SankyoBreast Cancer

Start: 1999-06-30End: 2002-04-30Updated: 2012-05-16

Chemotherapy in Treating Patients With Prostate Cancer

CompletedNCT00004045

Daiichi SankyoProstate Cancer

Start: 1999-06-30End: 2001-08-31Updated: 2012-05-16

DX-8951f in Treating Patients With Liver Cancer

CompletedNCT00004108

Daiichi SankyoLiver Cancer

Start: 1999-09-30End: 2005-04-30Updated: 2012-05-16

DX-8951f in Treating Patients With Biliary Cancer

CompletedNCT00005938

Daiichi SankyoExtrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer

Start: 2000-03-31End: 2005-04-30Updated: 2012-05-16

DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

CompletedNCT00005091

Daiichi PharmaceuticalsLung Cancer

Start: 1999-02-28End: 2003-08-31Updated: 2013-07-10

Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer

CompletedNCT00004060

Daiichi SankyoFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Start: 1999-07-31End: 2000-09-30Updated: 2012-05-16

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

CompletedNCT00003951

Daiichi SankyoPancreatic Cancer

Start: 1999-06-30End: 2005-04-30Target: 37Updated: 2012-05-16

Phase 3

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

CompletedNCT00023972

Daiichi SankyoPancreatic Cancer

Start: 2001-07-31End: 2005-04-30Updated: 2012-05-16